Exfo Inc (EXFO)

6.245  0 (-0.08%)

Fundamental Rating

2

Overall EXFO gets a fundamental rating of 2 out of 10. We evaluated EXFO against 54 industry peers in the Communications Equipment industry. EXFO may be in some trouble as it scores bad on both profitability and health. EXFO is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

EXFO had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -2.03%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -0.31%
PM (TTM) -2.18%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

EXFO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

EXFO has an Altman-Z score of 3.35. This indicates that EXFO is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.01 indicates that EXFO is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 3.35
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

EXFO has a Current Ratio of 1.45. This is a normal value and indicates that EXFO is financially healthy and should not expect problems in meeting its short term obligations.
EXFO has a Quick Ratio of 1.45. This is a bad value and indicates that EXFO is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 0.95

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 800.00% over the past year.
EXFO shows a small growth in Revenue. In the last year, the Revenue has grown by 7.09%.
EXFO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.64% yearly.
EPS 1Y (TTM)800%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-60%
Revenue 1Y (TTM)7.09%
Revenue growth 3Y2.96%
Revenue growth 5Y3.64%
Revenue growth Q2Q9.82%

3.2 Future

The Earnings Per Share is expected to grow by 113.35% on average over the next years. This is a very strong growth
EXFO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.24% yearly.
EPS Next Y807%
EPS Next 2Y225.35%
EPS Next 3Y150.19%
EPS Next 5Y113.35%
Revenue Next Year11%
Revenue Next 2Y9.68%
Revenue Next 3Y9.14%
Revenue Next 5Y11.24%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

EXFO is valuated quite expensively with a Price/Earnings ratio of 34.69.
EXFO is valuated rather expensively when we compare the Price/Earnings ratio to 28.06, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 36.37, which means the current valuation is very expensive for EXFO.
When comparing the Price/Forward Earnings ratio of EXFO to the average of the S&P500 Index (20.72), we can say EXFO is valued expensively.
Industry RankSector Rank
PE 34.69
Fwd PE 36.37

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.86

4.3 Compensation for Growth

EXFO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXFO's earnings are expected to grow with 150.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y225.35%
EPS Next 3Y150.19%

0

5. Dividend

5.1 Amount

EXFO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Exfo Inc

NASDAQ:EXFO (8/27/2021, 7:06:28 PM)

6.245

0 (-0.08%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap358.75M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 34.69
Fwd PE 36.37
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.03%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -0.31%
PM (TTM) -2.18%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.45
Quick Ratio 0.95
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)800%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y807%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.09%
Revenue growth 3Y2.96%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y